Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement 2022-01-31 19:00
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines 2021-12-22 19:00
1